Anixa Biosciences Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -348.0% | – | – | – | – | – | – | – | – | – | |
| – | +200.0% | +0.0% | +0.0% | -12.7% | -36.4% | -48.1% | -61.7% | -48.6% | -13.5% | +2.5% | -34.4% | +7.9% | -0.5% | -21.2% | -4.6% | -9.3% | +13,601.7% | -68.3% | +7.4% | +6.2% | +2.8% | -6.7% | +35.7% | -80.7% | -33.4% | -30.0% | +9.5% | -19.6% | -389.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | -4.7% | -42.0% | -70.4% | -21.8% | +338.0% | +17.0% | -15.0% | -67.4% | +91.6% | +412.6% | -35.7% | -28.9% | +91.3% | -20.0% | -26.3% | 0.0% | -16.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -49.9% | +22,521.4% | +49.2% | -51.6% | -67.0% | -77.1% | +2,936.4% | -36.8% | +4.0% | +90.4% | -15.5% | – | – | – | |
| – | -600.0% | – | – | -251.4% | – | -264.8% | – | -20.1% | -16.1% | +202.0% | -87.3% | -273.6% | – | – | +3,279.5% | -134.4% | – | -265.7% | – | – | – | -83.4% | +606.7% | -195.9% | – | +521.8% | -318.6% | – | -71.1% | |
| – | +0.0% | -50.0% | -100.0% | – | -48.0% | +141.5% | -97.5% | +1,492.0% | -76.0% | +193.8% | +22.1% | +2.9% | -86.0% | +6.9% | +336.3% | -82.3% | -100.0% | – | +719.5% | +167.5% | -79.4% | +27.2% | +356.9% | -91.0% | -100.0% | – | – | – | – | |
| – | +7.7% | – | -162.5% | – | -77.6% | -147.7% | -97.5% | +1,492.0% | +2,492.8% | – | -255.3% | +4,694.4% | – | -46.8% | -367.4% | – | -71.4% | -602.0% | – | +3,224.5% | -281.9% | – | -136.0% | -41.8% | +1,180.9% | +173.9% | -47.8% | – | +13.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | +131.5% | -50.9% | -59.8% | -93.7% | +1,827.1% | -100.0% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -62.2% | -95.6% | -61.0% | -2,815.0% | – | -4,337.3% | – | +125.0% | +65.4% | – | – | -100.0% | – | -100.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +98.3% | -185.7% | +0.0% | +0.0% | – | – | – | – | – | – | – | – | |
| – | -90.4% | – | – | +43.8% | -79.6% | -99.0% | +14,002.4% | +6.4% | +35.7% | +46.2% | -9.3% | +766.4% | -89.5% | -36.7% | +102.9% | -62.2% | +238.7% | +126.4% | -105.5% | -99.3% | – | -65.8% | +125.5% | +65.0% | +235.6% | -98.6% | -19.0% | +833.1% | -33.2% | |
| – | – | – | – | – | – | -352.7% | – | -112.3% | – | – | -179.0% | – | – | -136.7% | – | – | – | +341.0% | -59.1% | -286.6% | – | -133.3% | – | +571.4% | +676.3% | -173.8% | – | – | -107.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -369.6% | – | – | – | – | – | – | – | – | – |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.